An active host adaptive response is characterized by the existence of cytotoxic T cells and IFN‐γ‐induced programmed death‐ligand 1 (PD‐L1) expression in tumor cells (TCs), which predicts a high response rate to anti‐PD‐1/L1 therapy [8, 9]. The gene discussed is PDCD1; the disease is neoplasm.